Table 3.
Admission and end of treatment laboratory parameters of patients with COVID-19
| Admission | End of Treatment | |||||||
|---|---|---|---|---|---|---|---|---|
| Nonsevere group (n = 85) | Severe group (n = 35) | Z | P | Nonsevere Group (n = 85) | Severe Group (n = 35) | Z | P | |
| Leucocytes | 5150 (2230–10 850) | 5970 (2810–16 520) | −1.986 | 0.047 | 5410 (662–11 770) | 6710 (3460–14 340) | −3.456 | 0.001 |
| Neutrophils | 3110 (1110–8120) | 4270 (1740–13 770) | −3.199 | 0.001 | 2830 (4040–7090) | 4390 (3370–13 270) | −4.570 | <0.001 |
| Lymphocytes | 1330 (390–3030) | 1090 (560–2070) | −3.057 | 0.002 | 1770 (390–3800) | 1080 (240–2690) | −4.885 | <0.001 |
| Monocytes | 380 (40–940) | 330 (40–1380) | −1.58 | 0.114 | 350 (140–890) | 400 (190–770) | −1.395 | 0.163 |
| Eosinophils | 40 (0–290) | 30 (0–150) | −1.637 | 0.102 | 80 (0–320) | 90 (10–310) | −0.477 | 0.633 |
| Basophils | 20 (0–170) | 30 (0–600) | −1.239 | 0.215 | 20 (0–160) | 20 (10–70) | −1.746 | 0.081 |
| RBCs | 4.93 (3.98–5.82) | 4.81 (3.97–5.79) | −1.62 | 0.105 | 4.72 (3.88–5.89) | 4.57 (3.68–5.83) | −2.523 | 0.012 |
| Haemoglobin | 14.5 (9.6–17.7) | 13.8 (11.2–17.4) | −1.733 | 0.083 | 13.8 (9.2–17.9) | 12.6 (10.1–15.7) | −3.292 | 0.001 |
| Haematocrit | 42 (15.2–52.5) | 40.2 (33.9–49.7) | −1.952 | 0.051 | 40.5 (29.8–53.5) | 37.7 (31.1–96.6) | −2.339 | 0.019 |
| RDW | 13.3 (11.7–27.3) | 13.5 (12.3–17.1) | −1.497 | 0.135 | 13.3 (11.9–17.6) | 13.4 (12.1–17.2) | −1.381 | 0.167 |
| Platelets | 217000 (119000–488000) | 221000 (131000–506000) | −0.110 | 0.913 | 231000 (104000–441000) | 357000 (135000–654000) | −5.280 | <0.001 |
| Platecrit | 0.18 (0.1–0.37) | 0.18 (0.1–0.41) | −0.287 | 0.774 | 0.19 (0.08–0.37) | 0.28 (0.12–0.57) | −5.283 | <0.001 |
| DNI | 0.1 (0.1–9.5) | 0.1 (0.1–4.4) | −1.794 | 0.073 | 0.1 (0.1–5.5) | 0.1 (0–6.4) | −2.211 | 0.027 |
| NLR | 2.31 (0.47–9.63) | 4.04 (1.51–15.54) | −4.027 | <0.001 | 1.52 (0.57–7.29) | 3.72 (0.64–40) | −6.12 | <0.001 |
| PLR | 170 (60–620) | 220 (100–490) | −2.792 | 0.005 | 130 (60–420) | 300 (300–940) | −5.782 | <0.001 |
CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; RDW, red cell distribution width; DNI, delta neutrophil index; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; RBCs, red blood cells.
Mann–Whitney U analysis. Data are median (min-max).